Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of the American Pharmacists Association : Japha|September 18, 2004
Therapeutic risk management interventions: feasibility and effectivenessElizabeth Andrews, Alicia Gilsenan, Suzanne Cook
The Open Respiratory Medicine Journal|June 29, 2010
Assessing Primary Care Physician's Beliefs and Attitudes of Asthma Exacerbation Treatment and Follow-UpWilliam Lincourt, Richard H Stanford, Alicia Gilsenan, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 29, 2020
Teriparatide Did Not Increase Adult Osteosarcoma Incidence in a 15-Year US Postmarketing Surveillance StudyAlicia Gilsenan, Kirk Midkiff, David Harris, et al.
Pharmacoepidemiology and Drug Safety|September 7, 2020
Assessing the incidence of osteosarcoma among teriparatide users based on Medicare Part D and US State Cancer Registry DataAlicia Gilsenan, Kirk Midkiff, David Harris, et al.
Pharmaceutical Medicine|January 31, 2024
Physician Awareness of the Safe Use of Cyproterone Acetate in Europe: A Survey on the Effectiveness of Additional Risk Minimization MeasuresCarolyn Sweeney, Alicia Gilsenan, Brian Calingaert, et al.
Breast Cancer Research and Treatment|May 19, 2022
Incidence of adverse events with therapies targeting HER2-positive metastatic breast cancer: a literature reviewEdith A Perez, Chau Dang, Caleb Lee, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 2, 2021
Real-world evidence: Patient views on asthma in respiratory specialist clinics in AmericaJohn Oppenheimer, David J Slade, Beth A Hahn, et al.
Pageof 2